MEDISISS Outlines Reprocessor’s Role in Infection Control

                                                                          

REDMOND, OR, November 8, 2010 – MEDISISS, an FDA-registered medical device reprocessor, recently presented at the CASA (California Ambulatory Surgery Association) National Seminar and Certificate of Training Program. The Infection Control seminar, focusing on "Prevention and Surveillance in the ASC", included an overview by Brandi James, MEDISISS Senior Director of Quality Assurance, describing single use device reprocessing and the data required to bring a reprocessed product to market.

James provided the audience with an extensive list of process steps and strict regulatory requirements involved with the operation of a successful and compliant program.

In addition to addressing the appropriate processes that a reprocessor and ASC must take to meet these standards, James pointed out the Quality System Requirements which ensures reprocessors follow the same pertinent rules as OEM's (Original Equipment Manufacturers).

A key aspect of James' talk encompassed Reprocessing Process Validations relative to cleaning, packaging, and sterilizing, along with product performance. She explained the cleaning and sterilization process design methods employed by reprocessors such as MEDISISS. James concluded her presentation by discussing the key elements of a successful reprocessing program. She emphasized, "The most important component is for the healthcare facility to establish a strong partnership with their reprocessor".